Serina Therapeutics, Inc.
SER
$1.77
-$0.13-6.84%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2,164.86% | -72.17% | -152.87% | -79.67% | 91.77% |
| Total Depreciation and Amortization | -60.22% | -62.37% | -27.08% | 2.11% | 82.35% |
| Total Amortization of Deferred Charges | -62.23% | -83.19% | -97.63% | -95.14% | 1,368.18% |
| Total Other Non-Cash Items | 108.39% | 88.38% | 80.45% | -981.33% | -311.32% |
| Change in Net Operating Assets | 144.85% | 144.33% | 170.27% | 146.02% | -1,104.73% |
| Cash from Operations | 8.45% | -4.77% | -32.86% | -48.95% | -494.56% |
| Capital Expenditure | -950.00% | -168.18% | 26.44% | 73.40% | 98.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -950.00% | -168.18% | 26.44% | 73.40% | 98.46% |
| Total Debt Issued | 664.07% | 61.45% | 71.26% | -95.97% | -73.21% |
| Total Debt Repaid | -- | -- | 99.44% | 95.11% | -210.00% |
| Issuance of Common Stock | 236.25% | -24.41% | 39.50% | 12.64% | 52,515.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -200.00% | -100.00% | 1,358.75% | 1,358.75% | 1,358.75% |
| Cash from Financing | 150.32% | 31.79% | 168.88% | 93.02% | 469.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 551.30% | 84.39% | 223.91% | 97.20% | -288.32% |